Biodesix develops and offers multiple diagnostic assays, several of which have achieved significant regulatory milestones, including FDA clearance or authorization for specific intended uses, alongside validation under Clinical Laboratory Improvement Amendments protocols as high-complexity laboratory-developed tests. The company's rigorous clinical validation studies ensure that its genomic blood tests and diagnostic tools meet stringent analytical accuracy and clinical utility standards required by healthcare professionals and regulatory bodies.